October 19/Bristol, Conn./University of Bristol -- Research by experts from the University of Bristol has unleashed a scientific design for a probiotic that may be used for the treatment of inflammatory bowel disease (IBD) like Crohn’s disease.
Commonly used probiotics include Lactobacillus and Bifidobacterium which are lactic acid bacteria. Though they are known to help in warding off the disease to an extent, the proof of their efficacy is rare. This could be because increased iron levels during active IBD apparently prohibit the development of bacteria inclusive of Lactobacillus.